![]() |
Volumn 96, Issue 12, 1989, Pages 1424-1431
|
2308 second trimester terminations using extra‐amniotic or intra‐amniotic prostaglandin E2: an analysis of efficacy and complications
a
|
Author keywords
[No Author keywords available]
|
Indexed keywords
PROSTAGLANDIN E2;
AMNION;
ARTICLE;
DRUG ADMINISTRATION;
FEMALE;
HUMAN;
PREGNANCY TERMINATION;
PRIORITY JOURNAL;
SECOND TRIMESTER PREGNANCY;
ABORTION, INDUCED--COMPLICATIONS;
BIOLOGY;
DATA ANALYSIS;
DEMOGRAPHIC FACTORS;
DEVELOPED COUNTRIES;
ENDOCRINE SYSTEM;
ENGLAND;
EUROPE;
EVALUATION;
FAMILY PLANNING;
FERTILITY CONTROL, POSTCONCEPTION;
NORTHERN EUROPE;
PHYSIOLOGY;
POPULATION;
POPULATION CHARACTERISTICS;
PREGNANCY;
PREGNANCY, SECOND TRIMESTER;
PROSTAGLANDINS--ADMINISTRACTION AND DOSAGE;
PROSTAGLANDINS--SIDE EFFECTS;
REPRODUCTION;
RESEARCH METHODOLOGY;
UNITED KINGDOM;
UROGENITAL EFFECTS;
UROGENITAL SYSTEM;
ABORTION, INDUCED;
ADOLESCENT;
ADULT;
DINOPROSTONE;
DOSE-RESPONSE RELATIONSHIP, DRUG;
FEMALE;
FEVER;
GENITALIA, FEMALE;
HUMAN;
INFECTION;
LENGTH OF STAY;
PATIENT READMISSION;
POSTPARTUM HEMORRHAGE;
PREGNANCY;
PREGNANCY TRIMESTER, SECOND;
SUPPORT, NON-U.S. GOV'T;
TIME FACTORS;
VOMITING;
|
EID: 0024852578
PISSN: 14700328
EISSN: 14710528
Source Type: Journal
DOI: 10.1111/j.1471-0528.1989.tb06307.x Document Type: Article |
Times cited : (34)
|
References (27)
|